Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The daily decree has apparently gone out again....
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Well, and now take the number of OS in the first Dutton Report = 400mio outstanding shares and you could think that Pohl defines this as a target for the buyback. Fully diluted 42Xmio minus buyback equals 400mio OS. Just an idea...
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply